Yield10 Bioscience Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement
January 31 2020 - 1:30PM
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience
company that uses its “Trait Factory” to develop high value seed
traits for the agriculture and food industries, announced today
that it has received a letter from The Nasdaq Stock Market LLC
notifying the Company that it has regained compliance with the
Nasdaq Capital Market’s minimum bid price continued listing
requirement. The letter noted that as of January 30, 2020, the
Company evidenced a closing bid price of its common stock in excess
of the $1.00 minimum requirement for at least ten consecutive
trading days. Accordingly, the Company has regained compliance with
Nasdaq Marketplace Rule 5550(a)(2) and Nasdaq considers the matter
closed.
About Yield10
Bioscience
Yield10 Bioscience, Inc. is an agricultural
bioscience company which uses its “Trait Factory” to develop high
value seed traits for the agriculture and food industries to
achieve step-change improvements in crop yield to enhance global
food security and develop specialty crop products. Yield10 has an
extensive track record of innovation based around optimizing the
flow of carbon in living systems. The “Trait Factory” has two
components: the “GRAIN” computational modeling platform, which is
used to identify specific gene changes designed to improve crop
performance, and the deployment of those changes into crops using
genome-editing or traditional agricultural biotechnology
approaches. The purpose of the “Trait Factory” is to engineer
precise alterations to gene activity and the flow of carbon in
plants to produce higher yields with lower inputs of land, water or
fertilizer. Yield10 is advancing several yield traits it has
developed in crops such as canola, soybean, and corn. Yield10 is
headquartered in Woburn, MA and has an Oilseeds Center of
Excellence in Saskatoon, Canada.
For more information about the Company, please
visit the website and follow the Company on Twitter and
LinkedIn.
(YTEN-G)
Safe Harbor for Forward-Looking
Statements
This press release contains forward-looking
statements which are made pursuant to the safe harbor provisions of
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. The
forward-looking statements in this release do not constitute
guarantees of future performance. Investors are cautioned that
statements in this press release which are not strictly historical,
including, without limitation, Yield10’s ability to continue to
maintain compliance with Nasdaq listing rules, constitute
forward-looking statements. Such forward-looking statements are
subject to a number of risks and uncertainties that could cause
actual results to differ materially from those anticipated,
including the risks and uncertainties detailed in Yield10
Bioscience's filings with the Securities and Exchange Commission.
Yield10 assumes no obligation to update any forward-looking
information contained in this press release or with respect to the
matters described herein.
Contacts:
Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693,
LBrum@yield10bio.com
Investor Relations: Bret Shapiro, (561)
479-8566, brets@coreir.comManaging Director, CORE IR
Media Inquiries: Eric Fischgrund,
eric@fischtankpr.com FischTank Marketing and PR
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Apr 2023 to Apr 2024